Publicacións nas que colabora con Francisco Javier Blanco García (30)

2024

  1. Higher Synovial Immunohistochemistry Reactivity of IL-17A, Dkk1, and TGF-β1 in Patients with Early Psoriatic Arthritis and Rheumatoid Arthritis Could Predict the Use of Biologics

    Biomedicines, Vol. 12, Núm. 4

2023

  1. Increased synovial immunohistochemistry reactivity of TGF-β1 in erosive peripheral psoriatic arthritis

    BMC musculoskeletal disorders, Vol. 24, Núm. 1, pp. 246

2020

  1. Generation and characterization of human induced pluripotent stem cells (iPSCs) from hand osteoarthritis patient-derived fibroblasts

    Scientific Reports, Vol. 10, Núm. 1

2018

  1. Induced pluripotent stem cells for cartilage repair: Current status and future perspectives

    European Cells and Materials, Vol. 36, pp. 96-109

2017

  1. CD105+-mesenchymal stem cells migrate into osteoarthritis joint: An animal model

    PLoS ONE, Vol. 12, Núm. 11

  2. Human cartilage engineering in an In Vitro repair model using collagen scaffolds and mesenchymal stromal cells

    International Journal of Medical Sciences, Vol. 14, Núm. 12, pp. 1257-1262

  3. Ovine mesenchymal stromal cells: Morphologic, phenotypic and functional characterization for osteochondral tissue engineering

    PLoS ONE, Vol. 12, Núm. 1

2016

  1. 3, 3′, 5-triiodo-L-thyronine Increases In Vitro Chondrogenesis of Mesenchymal Stem Cells From Human Umbilical Cord Stroma Through SRC2

    Journal of Cellular Biochemistry, pp. 2097-2108

2013

  1. Human amniotic membrane: A potential tissue and cell source for cell therapy and regenerative medicine

    Emerging Trends in Cell and Gene Therapy (Humana Press Inc.), pp. 55-78

2012

  1. Proteome analysis during chondrocyte differentiation in a new chondrogenesis model using human umbilical cord stroma mesenchymal stem cells

    Molecular and Cellular Proteomics, Vol. 11, Núm. 2

2011

  1. Analysis of the chondrogenic potential and secretome of mesenchymal stem cells derived from human umbilical cord stroma

    Stem Cells and Development, Vol. 20, Núm. 7, pp. 1199-1212

  2. Bone marrow cells immunomagnetically selected for CD271+ antigen promote in vitro the repair of articular cartilage defects

    Tissue Engineering - Part A, Vol. 17, Núm. 7-8, pp. 1169-1179

  3. Human amniotic membrane as an alternative source of stem cells for regenerative medicine

    Differentiation, Vol. 81, Núm. 3, pp. 162-171

  4. Proteome analysis during a new chondrogenesis model from mesenchymal stem cells of human umbilical cord stroma

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 7, pp. 120-120

  5. Quantification of cells expressing mesenchymal stem cell markers in healthy and osteoarthritic synovial membranes

    Journal of Rheumatology, Vol. 38, Núm. 2, pp. 339-349

  6. Umbilical cord as a mesenchymal stem cell source for treating joint pathologies

    World Journal of Orthopaedics, Vol. 2, Núm. 6, pp. 43-50

2010

  1. Chondrogenic potential of subpopulations of cells expressing mesenchymal stem cell markers derived from human synovial membranes

    Journal of Cellular Biochemistry, Vol. 111, Núm. 4, pp. 834-845

  2. Isolation and characterization of mesenchymal stem cells from human amniotic membrane

    Tissue Engineering - Part C: Methods, Vol. 17, Núm. 1, pp. 49-59

  3. Multilineage differentiation potential of cells isolated from the human amniotic membrane

    Journal of Cellular Biochemistry, Vol. 111, Núm. 4, pp. 846-857

  4. Potential use of the human amniotic membrane as a scaffold in human articular cartilage repair

    Cell and Tissue Banking